Simon Rushbrook
Impact in
- Hepatology top 0.2%
- Liver Diseases and Immunity
- Hepatitis C virus research
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 40
- Liver Diseases and Immunity 28
- Hepatitis C virus research 7
- Epidemiology 24
- Liver Disease Diagnosis and Treatment 18
- Co-authors
- Nicholas Coleman (14 shared papers)Sarah L. Vowler (11 shared papers)Lesley S. Morris (7 shared papers)Esther Unitt (3 shared papers)Aileen Marshall (6 shared papers)Graeme J M Alexander (5 shared papers)Graeme Alexander (9 shared papers)Ian S. Scott (8 shared papers)
- Journals
- Hepatology (8 papers)Gastroenterology (6 papers)Journal of Hepatology (6 papers)Gut (5 papers)Nature Communications (4 papers)
- Partner nations
- United KingdomCanadaNorway
In The Last Decade
Simon Rushbrook
69 papers receiving 5.0k citations
Simon Rushbrook's Hit Papers
Peers
Comparison fields: 5 of 103
- Hepatology 2.4k
- Epidemiology 2.1k
- Oncology 775
- Immunology 580
- Surgery 1.1k
Countries citing papers authored by Simon Rushbrook
This map shows the geographic impact of Simon Rushbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Rushbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Rushbrook more than expected).
Fields of papers citing papers by Simon Rushbrook
This network shows the impact of papers produced by Simon Rushbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Rushbrook. The network helps show where Simon Rushbrook may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Rushbrook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Hit paper breakdown → | 2019 | 1063 |
| 2 | 2013 | 329 | |
| 3 | 2016 | 269 | |
| 4 | 2005 | 246 | |
| 5 | 2005 | 239 | |
| 6 | 2019 | 231 | |
| 7 | 2006 | 220 | |
| 8 | 2015 | 220 | |
| 9 | 2019 | 212 | |
| 10 | 2005 | 175 | |
| 11 | 2020 | 165 | |
| 12 | 2022 | 127 | |
| 13 | 2018 | 125 | |
| 14 | 2022 | 119 | |
| 15 | 2021 | 110 | |
| 16 | 2018 | 87 | |
| 17 | 2022 | 79 | |
| 18 | 2003 | 78 | |
| 19 | 2003 | 69 | |
| 20 | 2020 | 68 |
About Simon Rushbrook
Simon Rushbrook is a scholar working on Hepatology, Epidemiology, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 70 papers that have together received 5.2k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (28 papers), Liver Disease Diagnosis and Treatment (18 papers), Gallbladder and Bile Duct Disorders (7 papers), Hepatitis C virus research (7 papers), Inflammatory Bowel Disease (5 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers), Immune Cell Function and Interaction (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Hepatology (2.4k citations), Epidemiology (2.1k citations), Oncology (775 citations), Immunology (580 citations) and Surgery (1.1k citations). Simon Rushbrook has collaborated with scholars based in United Kingdom, Canada and Norway. Frequent co-authors include Nicholas Coleman, Sarah L. Vowler, Lesley S. Morris, Esther Unitt, Aileen Marshall, Graeme J M Alexander, Graeme Alexander, Ian S. Scott, William Gelson and Paul Klenerman. Their work appears in journals such as Hepatology, Gastroenterology, Journal of Hepatology, Gut and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.